HalozymeHALO
About: Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Employees: 373
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
82% more call options, than puts
Call options by funds: $23.1M | Put options by funds: $12.7M
65% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 55
9% more capital invested
Capital invested by funds: $6.46B [Q2] → $7.06B (+$599M) [Q3]
8% more funds holding
Funds holding: 454 [Q2] → 490 (+36) [Q3]
4% more repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 165
0.53% more ownership
Funds ownership: 96.99% [Q2] → 97.52% (+0.53%) [Q3]
64% less funds holding in top 10
Funds holding in top 10: 11 [Q2] → 4 (-7) [Q3]
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
9 analyst ratings
Piper Sandler Joseph Catanzaro 45% 1-year accuracy 14 / 31 met price target | 14%upside $52 | Neutral Maintained | 4 Nov 2024 |
JMP Securities Jason Butler 63% 1-year accuracy 24 / 38 met price target | 60%upside $73 | Market Outperform Maintained | 1 Nov 2024 |
HC Wainwright & Co. Mitchell Kapoor 42% 1-year accuracy 61 / 146 met price target | 49%upside $68 | Buy Maintained | 1 Nov 2024 |
HC Wainwright & Co. Mitchell Kapoor 42% 1-year accuracy 61 / 146 met price target | 42%upside $65 | Buy Reiterated | 25 Oct 2024 |
Wells Fargo Mohit Bansal 48% 1-year accuracy 11 / 23 met price target | 36%upside $62 | Equal-Weight Downgraded | 7 Oct 2024 |
Financial journalist opinion
Based on 14 articles about HALO published over the past 30 days
